Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI)

被引:17
作者
van der Laan, Eveline A. N. Zeeuw [1 ]
van der Velden, Saskia [1 ]
Porcelijn, Leendert [2 ]
Semple, John W. [3 ]
van der Schoot, C. Ellen [1 ]
Kapur, Rick [1 ]
机构
[1] Univ Amsterdam, Amsterdam UNC, Sanquin Res, Dept Expt Immunohematol,Amsterdam & Landsteiner L, Amsterdam, Netherlands
[2] Sanquin Diagnost Serv, Dept Immunohematol Diagnost, Amsterdam, Netherlands
[3] Lund Univ, Div Hematol & Transfus Med, Lund, Sweden
关键词
Transfusion-related acute lung injury; TRALI; Platelets; 34-1-2S; Lipids; Ceramide; NEUTROPHIL EXTRACELLULAR TRAPS; CELLS; CONTRIBUTES; LIGHT;
D O I
10.1016/j.tmrv.2020.08.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets are versatile cells which are capable of eliciting nonhemostatic immune functions, especially under inflammatory conditions. Depending on the specific setting, platelets may be either protective or pathogenic in acute lung injury and acute respiratory distress syndrome (ARDS). Their role in transfusion-related acute lung injury (TRALI) is less well defined; however, it has been hypothesized that recipient platelets and transfused platelets both play a pathogenic role in TRALI. Overall, despite conflicting findings, it appears that recipient platelets may play a pathogenic role in antibody-mediated TRALI; however, theft contribution appears to be limited. It is imperative to first validate the involvement of recipient platelets by standardizing the animal models, methods, reagents, and readouts for lung injury and taking the animal housing environment into consideration. for the involvement of transfused platelets in TRALI, it appears that predominantly lipids such as ceramide in stored platelets are able to induce TRALI in animal models. These studies will also need to be validated, and moreover, the platelet-derived lipid-mediated mechanisms leading to TRALI will need to be investigated. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 50 条
  • [21] Transfusion-Related Acute Lung Injury (TRALI): Current Clinical and Pathophysiologic Considerations
    Kelly Swanson
    Denis M. Dwyre
    Jessica Krochmal
    Thomas J. Raife
    Lung, 2006, 184 : 177 - 185
  • [22] Transfusion-Related Acute Lung Injury (TRALI): A Canadian Blood Services Research and Development Symposium
    Saidenberg, Elianna
    Petraszko, Tanya
    Semple, Elisabeth
    Branch, Donald R.
    TRANSFUSION MEDICINE REVIEWS, 2010, 24 (04) : 305 - 324
  • [23] Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections
    Williams, Dennis
    Rao, Marepalli
    Carey, Patricia
    JOURNAL OF CLINICAL APHERESIS, 2012, 27 (04) : 205 - 211
  • [24] The pathology of transfusion-related acute lung injury
    Dry, SM
    Bechard, KM
    Milford, EL
    Churchill, WH
    Benjamin, RJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (02) : 216 - 221
  • [26] Transfusion related acute lung injury (TRALI)
    Urbaniak, SJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) : 463 - 464
  • [27] Transfusion-related Acute Lung Injury: An Overview
    Bayat, Behnaz
    Sachs, Ulrich J.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (22) : 3236 - 3240
  • [28] Transfusion-related acute lung injury (TRALI): Potential pathways of development, strategies for prevention and treatment, and future research directions
    Tung, John-Paul
    Chiaretti, Sara
    Dean, Melinda M.
    Sultana, Annette J.
    Reade, Michael C.
    Fung, Yoke Lin
    BLOOD REVIEWS, 2022, 53
  • [29] Pathophysiology of transfusion-related acute lung injury
    Looney, Mark R.
    Gilliss, Brian M.
    Matthay, Michael A.
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (05) : 418 - 423
  • [30] Transfusion-related acute lung injury
    Looney, MR
    Gropper, MA
    Matthay, MA
    CHEST, 2004, 126 (01) : 249 - 258